Search

Where clinicians, researchers, educators, and industry leaders come together to collaborate and discover new life-changing cures. The Harvard Ophthalmology Centers of Excellence and Institutes are multidisciplinary collaborations that unite clinicians, educators, investigators, trainees, and...

Archive issues provided in PDF format Edition #26 Edition #25 Edition #24 Edition #23 Edition #22 Edition #21 Edition #20 Edition #19 Edition #18 Edition #17 Edition #16 Edition #15

Pre-Registration has closed, however onsite registration will be available ACRC/Macula returns to Boston on February 2-4, 2023

Inside issue #36: Artificial Intelligence in Ophthalmology Meet our New Glaucoma Specialists Review Websites Offer Insight into Patient Experience Dr. Miller Honored with Retina Research Awards Dr. D'Amore Elected to Prestigious Academy Download the full issue or read highlights below. Artificial...

Overview The Harvard Ophthalmology Mentoring Program was created in 2014 to direct and support junior faculty toward promotion. Mentors help mentees focus on clinical or investigative goals, keeping in mind the tripartite Harvard Medical School (HMS) mission: clinical or investigative expertise...

DOWNLOAD FULL ISSUE Listening, Innovating, and Adapting in Difficult Times In this issue, we take a look at how the department has risen to the challenges of these unprecedented times. We also highlight our inspiring achievements in education and faculty development. COVID-19: Rising to the...

Promoting inclusion, diversity, and equity in our department and institutions is a key guiding principle for Harvard Ophthalmology. Learn more about our departmental initiatives and programs that promote these values.

Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and More Sensitive than Exome Sequencing Departmental investigators and colleagues in the HMS Ophthalmology Ocular Genomics Institute (OGI) recently reported the development and characterization of a comprehensive...

How biomedical breakthroughs in anti-VEGF research have changed how we diagnose, treat, and save vision for patients with retinal disease. Annually, 500,000 ophthalmic patients in the United States and over 1 million worldwide are treated with all anti-VEGF agents combined. Anti-VEGF treatments have...

Staying Boston Strong! Improving ophthalmic disaster readiness and response planning. Focus on Ocular Trauma • Key Lessons Learned • Benchmark protocols for managing open-globe repairs April 15, 2013: Residents, fellows and faculty from Mass. Eye and Ear and Harvard Medical School (HMS) clinical...